New depot gives native and worldwide biopharmaceutical prospects
well timed entry to provides and drugs for medical trial websites and sufferers
to speed up medical trials within the area
BOSTON and DURHAM, N.C., Sept. 27, 2022 (GLOBE NEWSWIRE) — Parexel, a number one international medical analysis group (CRO) targeted on growth and supply of progressive new therapies to advance affected person well being, at the moment introduced the opening of a brand new medical trial provides and logistics depot in Suzhou, China. This strategically positioned facility gives native and worldwide biopharmaceutical prospects conducting medical trials within the area with well timed entry to provides and investigative therapies to distribute to medical websites and sufferers all over the world.
“Our Suzhou depot is located in a region with significant current and projected clinical trial growth, making it attractive for our global customers planning trials in the Asia/Pacific region as well as local Chinese Biotech customers preparing to go global,” mentioned Sanjay Vyas, EVP and Head, Safety & Logistics. “This new depot offers the end-to-end capabilities our customers need to support their clinical trial operations and ensure the needed supplies and treatments reach investigators and patients safely and quickly.”
The Suzhou depot is the newest addition to Parexel’s sturdy international community of depots and Coordination Hub and Distribution Centers strategically positioned throughout 4 continents, together with Berlin, Germany; Buenos Aires, Argentina; Quakertown, Pennsylvania, US; São Paulo, Brazil; and Singapore, Singapore. Parexel’s depots have supported greater than 1,900 research within the final 5 years.
Located within the Suzhou New District, the depot is provided with capabilities crucial to prospects’ wants together with temperature storage capabilities (-20ºC, 2-8ºC, 15-25ºC, -80ºC), secondary packaging and labeling, success and distribution, drug sourcing and extra. The new location additionally gives crucial medical trial provides, ancillary provides and laboratory logistics companies within the Asia/Pacific area.
“China is an important area of significant investment for drug developers and a strategic growth area for Parexel,” mentioned Vicky Hsu, Senior Vice President, Head of Greater China and Biotech Operations Asia/Pacific. “This latest investment in our clinical trial supplies and logistics infrastructure and capabilities underscores Parexel’s commitment to the region and to patients.”
Parexel is among the many largest and main CROs in Asia/Pacific, with greater than 20 years of expertise in China. The firm’s continued investments within the area and its medical trial provides and logistics options are an extension of its Patients-First focus, with a dedication to make sure that provides and therapies are correctly dealt with at each level alongside the journey and arrive to medical websites and sufferers on time.
About Parexel
One of the most important medical analysis organizations, Parexel helps the event of progressive new medicines to enhance the well being of sufferers. We present companies to assist life sciences and biopharmaceutical prospects in all places rework scientific discoveries into new therapies. From decentralized medical trials to regulatory consulting companies to leveraging actual world insights, our therapeutic, technical and useful capability is underpinned by a deep conviction in what we do. For extra data, go to parexel.com and comply with us on LinkedIn, Twitter, and Instagram.
MEDIA
Lori Preuit Dorer
+1 513 496 8121
[email protected]
Danaka Williams
+1 984 298 4207
[email protected]
